Publications
Publications
- ALL
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1997
- 1996
| 223 | HDAC6 Inhibitors Rescued the Defective Axonal Mitochondrial Movement in Motor Neurons Derived from the Induced Pluripotent Stem Cells of Peripheral Neuropathy Patients with HSPB1 Mutation. Kim JY, Woo SY, Hong YB, Choi H, Kim J, Choi H, Mook-Jung I, Ha N, Kyung J, Koo SK, Jung SC, Choi BO.Stem Cells Int. 2016;2016:9475981. doi: 10.1155/2016/9475981. | Link |
|---|---|---|
| 222 | Close Correlation of Monoamine Oxidase Activity with Progress of Alzheimer\'s Disease in Mice, Observed by in Vivo Two-Photon Imaging. Kim D, Baik SH, Kang S, Cho SW, Bae J, Cha MY, Sailor MJ, Mook-Jung I, Ahn KH. ACS Cent Sci. 2016 Dec 28;2(12):967-975. doi: 10.1021/acscentsci.6b00309. | Link |
| 221 | Amyloid β-interacting partners in Alzheimer\'s disease: From accomplices to possible therapeutic targets. Han SH, Park JC, Mook-Jung I. Prog Neurobiol. 2015 Dec 22. pii: S0301-0082(15)30036-8. |
Link |
| 220 | Amyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer\'s disease. Sung HY, Choi EN, Lyu D, Mook-Jung I, Ahn JH. PLoS One. 2014 Jun 25;9(6):e99047. doi: 10.1371/journal.pone.0099047. eCollection 2014. |
Link |
| 219 | Discovery of benzimidazole derivatives as modulators of mitochondrial function: A potential treatment for Alzheimer\'s disease. Kim T, Yang HY, Park BG, Jung SY, Park JH, Park KD, Min SJ, Tae J, Yang H, Cho S, Cho SJ, Song H,Mook-Jung I, Lee J, Pae AN. Eur J Med Chem. 2016 Nov 9;125:1172-1192. | Link |
| 218 | Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer\'s disease. Cha MY, Cho HJ, Kim C, Jung YO, Kang MJ, Murray ME, Hong HS, Choi YJ, Choi H, Kim DK, Choi H, Kim J, Dickson DW, Song HK, Cho JW, Yi EC, Kim J, Jin SM, Mook-Jung I. Hum Mol Genet. 2015 Nov 15;24(22):6492-504. | Link |
| 217 | Crucial role of calbindin-D28k in the pathogenesis of Alzheimer\'s disease mouse model. Kook SY, Jeong H, Kang MJ, Park R, Shin HJ, Han SH, Son SM, Song H, Baik SH, Moon M, Yi EC, Hwang D, Mook-Jung I. Cell Death Differ. 2014 Oct;21(10):1575-87. doi: 10.1038/cdd.2014.67. Epub 2014 May 23. | Link |
| 216 | Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer\'s disease. Kim DK, Han D, Park J, Choi H, Park JC, Cha MY, Woo J, Byun MS, Lee DY, Kim Y, Mook-Jung I. Exp Mol Med. 2019 Nov 15;51(11):1-17. |
Link |
| 215 | Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer\'s disease mouse model. Baik SH, Kang S, Son SM, Mook-Jung I. Glia. 2016 Dec;64(12):2274-2290. | Link |
| 214 | Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway. Son SM, Kang S, Choi H, Mook-Jung I. Mol Neurodegener. 2015 Oct 31;10(1):56. doi: 10.1186/s13024-015-0054-3. | Link |
